• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926024300
Device Problems Bent (1059); Device Damaged Prior to Use (2284)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event Description
It was reported that stent damage occurred.A 3.00 x 24 synergy ii drug eluting stent was selected to treat the lesion.However, during unpacking, it was noticed that the stent strut was flared out.The device was not used and the procedure was completed with a different device.
 
Manufacturer Narrative
Device evaluated by mfr: the stent delivery system was returned for analysis.A visual examination of the crimped stent found proximal stent damage with proximal struts 1 and 2 lifted and pulled distally overlapping strut 3.The distal and center part of the stent showed no signs of damage.The crimped stent outer diameter (od) on the undamaged side was measured and is within specification.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.The bumper tip of the device showed no signs of damage.A visual and tactile examination found no issues with the hypotube shaft.A visual and tactile examination of the outer and mid-shaft section found no issues.The inner lumen and bi-component bond showed no signs of damage or strain.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is considered handling damage as the event occurred without direct patient contact.(b)(4).
 
Event Description
It was reported that stent damage occurred.A 3.00 x 24 synergy ii drug eluting stent was selected to treat the lesion.However, during unpacking, it was noticed that the stent strut was flared out.The device was not used and the procedure was completed with a different device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6189170
MDR Text Key62851010
Report Number2134265-2016-11842
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840237
UDI-Public(01)08714729840237(17)20170824(10)19660585.
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/24/2017
Device Model NumberH7493926024300
Device Catalogue Number39260-2430
Device Lot Number19660585
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/15/2016
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/05/2016
Initial Date FDA Received12/20/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/23/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/12/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-